These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 36454342

  • 1. Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review.
    Quintero-González DC, Navarro-Beleño K, López-Gutiérrez LV, Muñoz-Urbano M, Vanegas-García AL, Muñoz-Vahos CH.
    Clin Rheumatol; 2023 Mar; 42(3):949-958. PubMed ID: 36454342
    [Abstract] [Full Text] [Related]

  • 2. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M.
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [Abstract] [Full Text] [Related]

  • 3. Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study.
    Zhou S, Lai J, Wu C, Liu Y, Liu Y, Zhao J, Xu D, Tian X, Li M, Zhao Y, Wang Y, Wang Q, Zeng X.
    Front Immunol; 2022 Jul; 13():928861. PubMed ID: 35983058
    [Abstract] [Full Text] [Related]

  • 4. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.
    J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
    [Abstract] [Full Text] [Related]

  • 5. Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.
    Xu A, Ye Y, Fu Q, Lian X, Chen S, Guo Q, Lu LJ, Dai M, Lv X, Bao C.
    Rheumatology (Oxford); 2021 Jul 01; 60(7):3343-3351. PubMed ID: 33331866
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinically amyopathic dermatomyositis : a rare entity associated with acute and severe interstitial lung disease].
    Debrus C, Calmes D, Von Frenckell C, Duysinx B, Cataldo D, Corhay JL, Louis R, Guiot J.
    Rev Med Liege; 2023 Jul 01; 78(7-8):441-447. PubMed ID: 37560958
    [Abstract] [Full Text] [Related]

  • 8. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD.
    J Am Acad Dermatol; 2006 Apr 01; 54(4):597-613. PubMed ID: 16546580
    [Abstract] [Full Text] [Related]

  • 9. Anti-MDA5 Antibody Spectrum in Western World.
    Moghadam-Kia S, Oddis CV, Aggarwal R.
    Curr Rheumatol Rep; 2018 Oct 31; 20(12):78. PubMed ID: 30382445
    [Abstract] [Full Text] [Related]

  • 10. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T.
    Medicina (Kaunas); 2021 Apr 03; 57(4):. PubMed ID: 33916864
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
    González-Moreno J, Raya-Cruz M, Losada-Lopez I, Cacheda AP, Oliver C, Colom B.
    Rheumatol Int; 2018 Jul 03; 38(7):1293-1296. PubMed ID: 29417209
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug 03; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 15. Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease.
    Sasaki N, Ishii A, Kurabayashi T, Sugiyama M, Izumi Y, Nakagome Y, Hirano K, Sasaki S, Kondo Y, Nogi S, Nishikawa A, Hosono Y, Yamada C, Sato S.
    Mod Rheumatol Case Rep; 2021 Jan 03; 5(1):87-94. PubMed ID: 33048020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.
    Huang K, Vinik O, Shojania K, Yeung J, Shupak R, Nimmo M, Avina-Zubieta JA.
    Rheumatol Int; 2019 Nov 03; 39(11):1971-1981. PubMed ID: 31375890
    [Abstract] [Full Text] [Related]

  • 20. Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud.
    Yang J, Yan B.
    Front Immunol; 2022 Nov 03; 13():1009546. PubMed ID: 36275649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.